CytomX Therapeutics, Inc. - COM (CTMX)

Q4 2017 13F Holders as of 12/31/2017

Type / Class
Equity / COM
Number of holders
119
Total Shares
30.1M
Shares change
+2.44M
Total reported value, excl. options
$637M
Value change
+$56M
Put/Call ratio
0
Number of buys
75
Number of sells
-36
Price
$21.11
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.